8–24 hours
- — Anxiety
- — yawning
- — runny nose
- — sweating
- — insomnia
- — muscle aches
Fentanyl is a synthetic opioid 50–100 times more potent than morphine.
Fentanyl is a synthetic opioid 50–100 times more potent than morphine. Illicit fentanyl is now the single largest driver of overdose deaths in Kentucky and nationwide, often mixed into counterfeit pills and other street drugs without the person knowing. Because of its potency, fentanyl addiction is exceptionally dangerous — and it is also treatable with evidence-based medication-assisted treatment (MAT) plus structured behavioral care.
Also known as: illicit fentanyl, synthetic opioid addiction, fent.
Every person's experience varies. The windows below describe typical clinical patterns — your plan will be adjusted based on how you respond.
Fentanyl withdrawal is acute. Nursing monitoring matters, and starting buprenorphine (Suboxone/Subutex) during withdrawal management helps people stay in treatment. Withdrawal management is completed before admission to Golden Grove.
Structured residential care provides safety during the early abstinence window when overdose risk from lost tolerance is highest.
Golden Grove's MAT for fentanyl use disorder is Suboxone, Subutex, and Vivitrol, delivered inside residential care, and buprenorphine and naltrexone are the FDA-approved options for opioid use disorder. Methadone is also FDA-approved for opioid use disorder but is delivered through separate licensed opioid treatment programs, not at Golden Grove.
Naloxone is available without a prescription in Kentucky, and pharmacists can explain how to use it. Naloxone is a Kentucky Medicaid benefit.
Fentanyl OUD frequently co-occurs with trauma, depression, and anxiety. Integrated dual-diagnosis care treats the mental health condition and the substance use together.
Kentucky's Office of Drug Control Policy recorded more than 2,000 overdose deaths in 2021, the state's peak year, with fentanyl detected in most of them. Annual totals have fallen since; check the current ODCP overdose fatality report for the latest figure. Jefferson County (Louisville) has consistently been among the most-affected counties in the state. The urgency of the fentanyl crisis makes rapid access to MAT and residential care a Kentucky Medicaid priority.
Kentucky Medicaid plans typically cover medical detox, residential treatment, and MAT for fentanyl opioid use disorder. Naloxone is also a Kentucky Medicaid pharmacy benefit for members at risk.
Coverage is determined by medical necessity using the American Society of Addiction Medicine (ASAM) criteria. Our admissions team verifies your specific plan on the call.
The clinical approach is similar — MAT plus behavioral care is the standard — but fentanyl's potency makes overdose risk during any relapse window substantially higher. Treatment emphasizes rapid MAT induction, longer stabilization, and universal naloxone access.
Fentanyl withdrawal is not typically life-threatening the way alcohol withdrawal is, but it is severe, and unmanaged withdrawal dramatically increases relapse and fatal overdose risk. Medical detox with MAT induction is strongly recommended.
Yes. Kentucky Medicaid plans typically cover medical detox, residential treatment, and MAT for fentanyl opioid use disorder.
Admissions answers 24/7. Golden Grove will accept Kentucky Medicaid. Coverage check happens on the call.